Novo Nordisk’s stock fell 5%, after its blockbuster weight-loss drug failed to prove useful for treating Alzheimer’s, while Alibaba’s answer to ChatGPT got over ten million downloads in a week – and earned the stock a tidy bump.

Today’s stories:

• Investors Punished Novo Nordisk For Its Trial And Error
• Investors Gave Alibaba’s AI App A Perfect Ten… Million Downloads

Try Finimize Pro